Comparison of Pacing Lead Design on Left Bundle Branch Pacing Outcomes

Last updated: October 2, 2024
Sponsor: National University Hospital, Singapore
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Fixed helix, lumenless pacing lead.

Extendable helix, stylet-driven pacing lead.

Stylet-driven pacing lead.

Clinical Study ID

NCT06318130
LEAD-LBP
  • Ages > 21
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This trial seeks to evaluate the performance of the extendable helix, stylet-driven pacing lead (SDL) compared to the fixed helix, lumenless pacing lead (LLL) during left bundle branch pacing (LBBP), with respect to enduring left bundle branch capture on follow-up, incidence of acute lead failure, pacing characteristics including QRS duration, pacing thresholds, R-wave amplitudes and lead impedance, and finally, safety profile during LBBP implantation. These data will guide future lead selection during LBBP implantation in achieving improved procedural success and optimal lead performance.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Fulfil current indications for pacemaker therapy according to internationalguideline recommendations:

  2. Symptomatic sinus bradycardia/sinus node dysfunction or AV block requiringpacemaker insertion.

  3. Symptomatic heart failure, left ventricular ejection fraction (LVEF) <35%, leftbundle branch block and QRS duration >120ms.

  4. Symptomatic heart failure, left ventricular ejection fraction (LVEF) <35%,right bundle branch block and QRS duration >150ms.

  5. LVEF <50% with significant anticipated ventricular pacing requirement of ≥20%.

  6. Age ≥21 years old

  7. Able to provide informed consent

  8. Planned LBBP implantation

Exclusion

Exclusion Criteria:

  1. Severe tricuspid regurgitation or previous tricuspid valve intervention requiringimplantation of left ventricular lead in the coronary sinus.

  2. Unable to provide informed consent.

  3. Pregnant women.

  4. <21 years of age.

Study Design

Total Participants: 210
Treatment Group(s): 4
Primary Treatment: Fixed helix, lumenless pacing lead.
Phase:
Study Start date:
January 01, 2023
Estimated Completion Date:
June 30, 2025

Study Description

This study is a single-blind, randomised controlled trial, aimed at evaluating the performance of the extendable helix, stylet driven pacing lead (SDL) compared to the fixed helix, lumenless pacing lead (LLL) during left bundle branch pacing (LBBP). The study is a multicentre study across 3 major hospitals in Singapore, and LBBP performed by independent electrophysiologists experienced in performing LBBP.

The primary objective of the study is to determine differences in incidence of loss of left bundle capture by pacing lead design (LLL vs SDL). The secondary objectives are to determine if lead design affects frequency of lead failure during implantation, investigate differences in short- and medium-term LBBP parameters on follow-up by lead design, and evaluate differences in safety profile between LLL and SDL in LBBP.

This study aims to recruit a target of 210 patients. A previous retrospective study found a loss of LB capture rate of 9% with LLL and 25% with SDL. A sample size of 170 will be required for a type-1 error rate of 5% and power of 80%. Accounting for a dropout rate of 20%, a total of 210 patients will be recruited (105 per group). Eligible subjects will be randomised to either the LLL or the SDL arm. The randomisation list will be generated with a computer-generated sequence in permuted blocks of 4, stratified by centre, to ensure a final allocation ratio of 1:1.

Connect with a study center

  • National University Heart Centre Singapore

    Singapore,
    Singapore

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.